Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

    H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

    FromNeuro-Oncology: The Podcast

    Start listeningView podcast show

    H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

    FromNeuro-Oncology: The Podcast

    ratings:
    Length:
    22 minutes
    Released:
    Mar 25, 2022
    Format:
    Podcast episode

    Description

    Dr. Iyad Alnahhas interviews Dr. Carl Koschmann about his and his team's recent manuscript entitled: "Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma" published online in Neuro-Oncology in February 2022. Read the Study
    Released:
    Mar 25, 2022
    Format:
    Podcast episode

    Titles in the series (85)

    Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.